The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2007
DOI: 10.1021/ac061692y
|View full text |Cite
|
Sign up to set email alerts
|

Parallel Nanoliter Microfluidic Analysis System

Abstract: A parallel nanoliter microfluidic analysis system based on capillary action, centrifugal force, and hydrophobic barriers is described. The precision of 112 parallel volume definition operations is determined to 0.75% CV at 200 nL using the individual sample introduction structure. For 20 nL, the actual measurement error is the dominating factor, with a combined error of 1.9% CV. Individual dispensing as well as dispensing through a common distribution channel is described. The volume definition precision for t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
68
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(71 citation statements)
references
References 31 publications
0
68
0
Order By: Relevance
“…IgG1 was captured from a crude cell supernatant using protein A beads and the N-glycans were released with PNGase F. Glycans were purified with a graphitized carbon black column, and both this stage and crystallization for MALDI-TOF analysis were performed on the CD (Andersson et al, 2007;Thuy et al, 2010). Tep et al (2012b) have developed a method for looking at glycomic changes that occur in CHO cells other than those associated with the expressed biotherapeutic.…”
Section: Biopharmaceuticalsmentioning
confidence: 99%
“…IgG1 was captured from a crude cell supernatant using protein A beads and the N-glycans were released with PNGase F. Glycans were purified with a graphitized carbon black column, and both this stage and crystallization for MALDI-TOF analysis were performed on the CD (Andersson et al, 2007;Thuy et al, 2010). Tep et al (2012b) have developed a method for looking at glycomic changes that occur in CHO cells other than those associated with the expressed biotherapeutic.…”
Section: Biopharmaceuticalsmentioning
confidence: 99%
“…11) is an open, parallel nanoliter microfluidic analysis system [18] which allows the development of new assays if suitable biotinylated antigens are available. The streptavidin-coated beads are activated with biotinylated capture reagents as the first step in the immunoassay.…”
Section: Technical Trends In Immunoassaysmentioning
confidence: 99%
“…In contrast to pressure-driven microfluidic approaches, centrifugal microfluidic systems can be filled with regular pipettes and intrinsically benefit from low dead volumes since no liquid is lost in tubings. 19 This simple "world-to-chip" interface and low dead volumes have led to the adoption of centrifugal microfluidic platforms in diverse diagnostic 20,21 and analytical 22 applications. Especially noteworthy are centrifugal microfluidic systems for protein crystallography.…”
Section: Introductionmentioning
confidence: 99%